Evolve Private Wealth LLC Invests $1.10 Million in Plexus Corp. $PLXS

Evolve Private Wealth LLC acquired a new stake in shares of Plexus Corp. (NASDAQ:PLXSFree Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,666 shares of the technology company’s stock, valued at approximately $1,102,000.

A number of other hedge funds also recently added to or reduced their stakes in PLXS. Hodges Capital Management Inc. lifted its position in Plexus by 47.7% in the 4th quarter. Hodges Capital Management Inc. now owns 17,950 shares of the technology company’s stock valued at $2,639,000 after purchasing an additional 5,795 shares during the last quarter. Louisiana State Employees Retirement System acquired a new position in Plexus during the 1st quarter valued at about $2,410,000. Jefferies Financial Group Inc. bought a new position in Plexus in the 4th quarter worth about $2,182,000. Walleye Capital LLC bought a new position in Plexus in the 2nd quarter worth about $8,296,000. Finally, GSA Capital Partners LLP increased its stake in shares of Plexus by 159.6% in the fourth quarter. GSA Capital Partners LLP now owns 14,638 shares of the technology company’s stock valued at $2,152,000 after purchasing an additional 8,999 shares during the period. 94.45% of the stock is currently owned by institutional investors.

Plexus Price Performance

Shares of PLXS stock opened at $240.14 on Monday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.72 and a current ratio of 1.49. The stock has a market cap of $6.43 billion, a PE ratio of 35.42 and a beta of 0.90. The business’s fifty day moving average is $269.04 and its 200-day moving average is $242.86. Plexus Corp. has a 1 year low of $131.37 and a 1 year high of $307.06.

Plexus (NASDAQ:PLXSGet Free Report) last released its earnings results on Wednesday, July 29th. The technology company reported $2.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.13 by $0.19. Plexus had a return on equity of 12.46% and a net margin of 4.03%.The firm had revenue of $1.30 billion for the quarter, compared to analyst estimates of $1.23 billion. During the same period in the previous year, the company earned $1.64 earnings per share. Plexus’s revenue was up 28.2% compared to the same quarter last year. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. Equities analysts expect that Plexus Corp. will post 7.11 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

PLXS has been the topic of a number of recent analyst reports. Weiss Ratings cut Plexus from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday, August 11th. Wall Street Zen raised Plexus from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Sidoti upgraded Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price target for the company in a research report on Friday, July 31st. Zacks Research upgraded Plexus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $310.00 price target on shares of Plexus in a research note on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $273.00.

Check Out Our Latest Stock Analysis on PLXS

Insider Buying and Selling at Plexus

In other news, insider Michael J. Running sold 510 shares of the business’s stock in a transaction on Friday, June 5th. The stock was sold at an average price of $272.17, for a total transaction of $138,806.70. Following the sale, the insider directly owned 665 shares of the company’s stock, valued at $180,993.05. The trade was a 43.40% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Michael V. Schrock sold 4,000 shares of the stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $275.00, for a total value of $1,100,000.00. Following the completion of the transaction, the director owned 40,329 shares of the company’s stock, valued at $11,090,475. This trade represents a 9.02% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 9,510 shares of company stock valued at $2,622,497. Corporate insiders own 1.78% of the company’s stock.

Plexus Profile

(Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Read More

Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXSFree Report).

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.